Home/Filings/4/0001209191-23-003383
4//SEC Filing

BAYS F BARRY 4

Accession 0001209191-23-003383

CIK 0001630627other

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 9:00 PM ET

Size

9.6 KB

Accession

0001209191-23-003383

Insider Transaction Report

Form 4
Period: 2023-01-11
BAYS F BARRY
Director
Transactions
  • Sale

    Common Stock

    2023-01-11$24.32/sh9,719$236,3661,436,793 total
  • Sale

    Common Stock

    2023-01-12$25.13/sh23,695$595,5001,413,098 total
  • Sale

    Common Stock

    2023-01-12$25.94/sh21,841$566,6391,391,257 total
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  • [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.0500 to $24.755 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]Due to an inadvertent error, the value in Table 1, Box 5 of the Form 4 filed on September 29, 2022 was incorrectly reported. This value corrects the aforementioned error.
  • [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.5500 to $25.5400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5500 to $25.9900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

TREACE MEDICAL CONCEPTS, INC.

CIK 0001630627

Entity typeother

Related Parties

1
  • filerCIK 0001183554

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 9:00 PM ET
Size
9.6 KB